Uncertainties About the Optimal Timing of Fourth Dose of COVID-19 Vaccines-Reference-Cited by-同舟云学术

Uncertainties About the Optimal Timing of Fourth Dose of COVID-19 Vaccines

Published:2022-07-21 Issue:7 Volume:5 Page:e2223096
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Nealon Joshua¹,Cowling Benjamin J.¹²

Affiliation:

1. World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China

2. Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2794466/nealon_2022_ic_220144_1657735396.48676.pdf

Reference6 articles.

1. Duration of protection against mild and severe disease by COVID-19 vaccines.;Andrews;N Engl J Med,2022

2. Antibody titers after a third and fourth SARS-CoV-2 BNT162b2 vaccine dose in older adults.;Eliakim-Raz;JAMA Netw Open

3. Immunological considerations for COVID-19 vaccine strategies.;Jeyanathan;Nat Rev Immunol,2020

4. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.;Dan;Science,2021

5. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.;Letizia;Lancet Respir Med,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Waning Humoral Immune Response Following the Third and Fourth SARS‐COV‐2 Vaccine: A Cohort Study in Healthcare Workers;Influenza and Other Respiratory Viruses;2024-08-27

2. Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance;2024-06-30

3. COVID-19 Booster Vaccine Hesitancy in the Emergency Department;Annals of Emergency Medicine;2023-10

4. Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up;International Journal of Molecular Sciences;2023-04-04

5. COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series;iScience;2023-04